CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ 49,904	$ (307,218)	$ (543,690)
Adjustments to net income (loss):
Depreciation and amortization	645,292	665,072	693,382
Deferred income tax expense (benefit)	15,881	7,335	(10,711)
Impairments and other charges	8,318		72,497
Amortization of debt discount and deferred financing costs	8,735	8,138	21,359
Losses (gains) on debt buyback	(25,275)	(4,119)	(13,423)
Losses (gains) on long-lived assets, net	13,920	7,352	23,864
Provision (recovery) of bad debt	31		(2,515)
Share-based compensation	15,839	15,828	19,362
Foreign currency transaction losses (gains), net	37,286	6,689	4,800
Mark-to-market (gain) loss on warrants	(54,684)	95,909
Net gain related to investment in Vast	(7,167)
Noncontrolling interest	(61,688)	(43,043)	(25,582)
Other	2,396	869	1,298
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(27,129)	(54,501)	71,805
Inventory	(19,432)	928	32,037
Other current assets	11,644	3,690	14,166
Other long-term assets	(1,283)	(11,196)	17,914
Trade accounts payable and accrued liabilities	(32,389)	61,636	12,143
Income taxes payable	24,135	8,616	5,140
Other long-term liabilities	33,528	39,104	34,930
Net cash provided by (used for) operating activities	637,862	501,089	428,776
Cash flows from investing activities:
Purchases of investments	(38,283)	(21,116)	(14,697)
Capital expenditures	(540,851)	(373,445)	(234,040)
Proceeds from sales of assets	14,133	26,713	124,301
Other	(5,423)	(860)	7,211
Net cash (used for) provided by investing activities	(570,424)	(368,708)	(117,225)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	900,000		700,000
Reduction in long-term debt	(298,474)	(182,601)	(186,958)
Debt issuance costs	(18,310)	(3,864)	(16,339)
Proceeds from revolving credit facilities	290,000	335,000	1,025,000
Reduction in revolving credit facilities	(290,000)	(795,000)	(1,237,500)
Dividends to common and preferred shareholders	(194)	(65)	(7,380)
Redeemable noncontrolling interest distribution related to Sanad		(10,324)	(58,524)
Distributions to noncontrolling interest	(2,269)	(3,489)	(3,795)
Special purpose acquisition company redemptions by non-controlling redeemable shareholders	(286,366)
Sale of non-controlling interest - special purpose acquisition company	305,000		276,000
Other	(6,795)	(1,189)	(2,083)
Net cash (used for) provided by financing activities	592,592	(661,532)	488,421
Effect of exchange rate changes on cash and cash equivalents	(22,988)	(7,219)	(1,742)
Net increase (decrease) in cash and cash equivalents and restricted cash	637,042	(536,370)	798,230
Cash and cash equivalents and restricted cash, beginning of period	737,140	1,273,510	475,280
Cash and cash equivalents and restricted cash, end of period	1,374,182	737,140	1,273,510
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	451,025	991,471	472,246
Restricted cash, beginning of period	286,115	282,039	3,034
Cash and cash equivalents and restricted cash, beginning of period	737,140	1,273,510	475,280
Cash and cash equivalents, end of period	1,057,487	451,025	991,471
Restricted cash, end of period	$ 316,695	$ 286,115	$ 282,039
Restricted cash, Balance Sheet location	Restricted cash held in trust	Restricted cash held in trust	Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period	$ 1,374,182	$ 737,140	$ 1,273,510